Leptospirosis approach diagnosis management and treatment

Reading File
Finding Sources
Finding Sources
Searching PubMed

leptospirosis diagnosis management treatment

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive, authoritative content from Harrison's 22E and Goldman-Cecil. Let me compile the full answer.

Leptospirosis: Approach, Diagnosis, Management and Treatment


1. Overview

Leptospirosis is a zoonotic bacterial infection caused by pathogenic spirochetes of the genus Leptospira (most commonly L. interrogans). It is the world's most widespread zoonosis, causing approximately 1 million clinical infections and ~58,900 deaths per year - numbers that are likely underestimates due to frequent misdiagnosis as dengue, malaria, or influenza.
  • Harrison's Principles of Internal Medicine, 22E
  • Goldman-Cecil Medicine

2. Microbiology

  • Thin, coiled, highly motile spirochetes (0.1 µm diameter, 6-20 µm long)
  • The trailing end forms a hook/question mark shape in fluid - hence "L. interrogans"
  • Gram stain does not work; visible only by dark-field microscopy or silver impregnation staining
  • Require special media for culture (weeks to months to grow)
  • 260 pathogenic serovars arranged in 26 serogroups
  • Key serovar-host associations:
    • Icterohaemorrhagiae/Copenhageni - rats (most important urban reservoir)
    • Hardjo - cattle
    • Canicola - dogs
    • Pomona - pigs

3. Epidemiology & Transmission

Reservoir: Rodents (especially Rattus norvegicus), dogs, pigs, cattle, horses. Animals shed leptospires in urine persistently without becoming ill.
Transmission to humans:
  • Contact with water/soil contaminated with infected animal urine
  • Through broken skin, cuts, abrasions, or mucous membranes (conjunctival, oral)
  • Rarely: direct animal bites, laboratory accidents
High-risk groups:
  • Farmers, slaughterhouse workers, veterinarians, sewer workers, rodent exterminators
  • Recreational exposure: swimming, waterskiing, mud-runs, whitewater rafting
  • Travelers to Southeast Asia, India, Malaysia, Brazil
  • Populations in flood-prone, low-income settings
Season: Summer/fall in temperate climates; rainy season in tropics. Epidemic peaks after flooding.

4. Pathogenesis

  1. Entry via abraded skin or mucous membranes
  2. Leptospires proliferate, cross tissue barriers, and disseminate hematogenously
  3. Outer membrane contains LPS, cytotoxic glycolipoprotein (GLP), and lipoproteins (especially LipL32) - these drive endothelial injury and organ damage
  4. GLP disrupts tubular Na+/K+-ATPase - explaining AKI and paradoxical hypokalemia
  5. Glycocalyx and endothelial injury cause capillary leak and multi-organ failure
  6. Leptospires have special tropism for the kidneys - AKI is nearly universal in severe disease

5. Clinical Manifestations

Leptospirosis follows a biphasic pattern, though this is not always clinically distinct:

Phase 1: Leptospiremic Phase (Days 1-7)

  • Abrupt onset high fever (38.5-40°C), severe headache, myalgia (especially calf muscles - characteristic)
  • Conjunctival suffusion (without discharge) - highly characteristic sign
  • Nausea, vomiting, diarrhea
  • Non-productive cough
  • Leptospires detectable in blood and CSF

Phase 2: Immune/Leptospiruric Phase (Days 7-14)

  • Most patients improve spontaneously
  • ~10% progress to severe disease (Weil's disease or pulmonary hemorrhage syndrome)
  • Leptospires detectable in urine; antibodies appear

Weil's Disease (Severe Leptospirosis)

Classic triad: Jaundice + Acute renal insufficiency + Bleeding
  • Jaundice (conjugated/direct hyperbilirubinemia; transaminases only moderately raised - unlike viral hepatitis)
  • Oliguric AKI (AKI incidence 10-80%; oliguric in 60%)
  • Bleeding: petechiae, ecchymoses; severe GI or pulmonary hemorrhage
  • Thrombocytopenia + coagulopathy (elevated INR, aPTT, D-dimer)
  • Cardiac arrhythmias
  • Aseptic meningitis (CSF: lymphocytic pleocytosis, elevated protein, normal glucose)
  • Case fatality rate up to 10% overall; higher with multiorgan involvement

Severe Pulmonary Hemorrhage Syndrome (SPHS)

  • Diffuse alveolar hemorrhage, ARDS
  • Chest CT: ground-glass opacities and airspace nodules
  • High mortality; may occur without jaundice

6. Diagnosis

Approach

"A provisional diagnosis of acute leptospirosis should be based primarily on clinical and epidemiologic grounds so as to enable early treatment." - Goldman-Cecil Medicine
Suspect leptospirosis in:
  • Acute febrile illness (≥38.5°C) + severe headache
  • Relevant exposure history (animals, floods, travel to endemic area)
  • Conjunctival suffusion + calf muscle tenderness (highly specific combination)
  • Cough with hemoptysis, jaundice, oliguria, meningismus

Case Definitions (WHO/National)

CategoryCriteria
SuspectFever ≥38.5°C + headache + myalgia + history of exposure
ProbableSuspect + any of: conjunctival suffusion / meningismus / calf tenderness / jaundice / oliguria / hemorrhage / IgM positive
ConfirmedSuspect/Probable + isolation of leptospires, positive PCR, seroconversion or 4-fold MAT titer rise, or single MAT titer ≥400

Laboratory Tests

Direct Detection (early disease, before antibiotics):
  • PCR (blood, urine, or CSF) - most sensitive; now feasible even in resource-poor settings; test of choice in first week
  • Blood culture in special media (EMJH medium) - takes weeks; low yield after antibiotics
  • Urine culture - positive from day 7 onwards
Serology (from day 5-7 onwards):
  • MAT (Microscopic Agglutination Test) - gold standard; serogroup-specific; single titer ≥1:400 (or ≥400) OR 4-fold rise in paired samples = diagnostic
  • IgM ELISA (Leptocheck, Lepto lateral flow) - rapid, early detection; becomes positive in week 1
  • Note: Serology may be negative early - do not rely on it to rule out acute infection
Non-specific but supportive:
  • Leukocytosis (>80% neutrophils)
  • Thrombocytopenia
  • Elevated CRP and procalcitonin (helps differentiate from dengue)
  • Elevated direct bilirubin with only moderate transaminase elevation
  • Elevated creatinine/BUN, pyuria, hematuria, proteinuria
  • CSF: aseptic meningitis pattern
  • Chest CT in suspected SPHS: ground-glass + airspace nodules

Differential Diagnosis

ConditionDistinguishing features
MalariaParasitemia on thick film; cyclical fever
DengueRash early, NS1/IgM dengue; normal procalcitonin
TyphoidStep-ladder fever, rose spots, Widal/blood culture
Scrub typhusEschar, tick exposure, Weil-Felix
Viral hepatitisVery high transaminases, no conjunctival suffusion
HantavirusHemorrhagic fever with renal syndrome, rodent exposure
Bacterial sepsisBlood cultures, focal source
Useful diagnostic clues distinguishing leptospirosis: conjunctival suffusion, calf/muscle tenderness, pulmonary hemorrhage - Goldman-Cecil Medicine

7. Treatment

Antibiotics (Table 189-1, Harrison's 22E)

IndicationRegimenDuration
Mild (outpatient)Doxycycline 100 mg PO twice daily7 days
OR Amoxicillin 500 mg PO three times daily7 days
OR Azithromycin 500 mg PO once daily3-5 days
Moderate/Severe (inpatient, IV)Penicillin G 1.5 million units IV q6h7 days
OR Ceftriaxone 1-2 g IV once daily7 days
OR Cefotaxime 1 g IV q6h7 days
OR Doxycycline IV (200 mg loading, then 100 mg q12h)7 days
PregnancyAzithromycin 500 mg PO once daily (3 days) OR Amoxicillin 500 mg PO three times daily7 days
Key antibiotic notes:
  • Leptospira susceptible to: beta-lactams, cephalosporins, aminoglycosides, macrolides, tetracyclines
  • Leptospira NOT susceptible to: vancomycin, rifampicin, metronidazole, chloramphenicol
  • No antibiotic resistance reported to date
  • No significant difference in outcomes between penicillin, ceftriaxone, cefotaxime, and doxycycline for severe disease (open-label RCTs)
  • Jarisch-Herxheimer reaction may occur hours after starting antibiotics (fever, chills, tachycardia, hypotension) - manage supportively

8. Supportive Management

Fluid & Electrolyte Management

  • Aggressive IV fluid resuscitation to correct dehydration and prevent oliguric AKI
  • Hypokalemia is characteristic and common - supplement potassium
  • Monitor urine output closely

Renal Replacement Therapy

  • Prompt initiation of peritoneal dialysis or hemodialysis for oliguric renal failure
  • Usually needed only short-term; rapid initiation shown to reduce mortality
  • Continuous venovenous hemofiltration (CVVH) preferred with multiorgan involvement or pulmonary edema

Pulmonary Hemorrhage / ARDS

  • Protective ventilation: low tidal volumes (<6 mL/kg) + high PEEP
  • ECMO has been used successfully for refractory respiratory failure
  • Consider early intubation

Other Complications

  • Cardiac monitoring for arrhythmias
  • Platelet/FFP transfusion for severe coagulopathy/hemorrhage
  • Avoid nephrotoxic drugs

9. Chemoprophylaxis

IndicationRegimen
Short-term high-risk exposure (e.g., flooding, travel)Doxycycline 200 mg PO once weekly
AlternativeAzithromycin 250 mg PO once or twice a week
Note: Efficacy of doxycycline prophylaxis in endemic/epidemic settings remains unclear. Azithromycin may be preferable in some contexts.

10. Prevention

  • Avoid contact with potentially contaminated water/soil (especially with broken skin)
  • Personal protective equipment: boots, gloves, goggles, waterproof overalls
  • Rodent control measures
  • Immunization of domestic animals
  • Vaccination available for humans in some countries (Cuba, China, France) - serovar-specific, limited cross-protection
  • Public health: flood management, improved sanitation, rodent surveillance

Summary Flowchart

Acute febrile illness + exposure history
           ↓
Clinical suspicion: fever + headache + myalgia + conjunctival suffusion + calf tenderness
           ↓
Start empiric therapy immediately (do NOT wait for confirmation)
           ↓
Send: PCR (blood/urine) + IgM ELISA + MAT (acute & convalescent serum)
           ↓
     Mild disease?              Severe/Weil's disease?
         ↓                              ↓
  Oral doxycycline          IV Penicillin G / Ceftriaxone
  or amoxicillin            + aggressive supportive care
  (7 days)                  + dialysis if oliguric AKI
                            + protective ventilation if ARDS

Sources:
  • Harrison's Principles of Internal Medicine, 22nd Edition (2025), Chapter 189
  • Goldman-Cecil Medicine, Chapter 298
  • Comprehensive Clinical Nephrology, 7th Edition, Chapter 71
  • Dengue-leptospirosis coinfection meta-analysis (BMC Infect Dis, 2025, PMID 39856559) - notes overlap in coinfection settings, reinforcing the need for dual testing in endemic regions
This is a shared conversation. Sign in to Orris to start your own chat.